Month: February 2024

12 Weeks of Treatment with EOHILIA May Address Significant Unmet Needs of Patients 11 Years of Age and Older EoE Is a Chronic Disease That Can Significantly Impact Patients, with Esophageal Inflammation and Intermittent Symptoms of Choking and Difficult or Painful Swallowing OSAKA, Japan and CAMBRIDGE, Massachusetts, February 12, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that…

February 16, 2024 Today, the U.S. Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in certain adults and children 1 year or older for the reduction of allergic reactions (Type I), including reducing the risk of anaphylaxis, that may occur with accidental exposure to one or more foods. Patients who take Xolair…

Have your eyes been itchy and driving you crazy? It might not be what you think it is. Allergic conjunctivitis with hay fever, dry eye, pink eye or blepharitis could lead to wrong treatment and side effects.With an estimated 50 million white blood “mast” cells, the eye can sense irritants and release histamine and other…

For many patients with asthma, their asthma is controlled by identifying and avoiding triggers, taking a daily inhaled or oral controller medication, and using a quick-relief inhaler when symptoms develop. For some patients though, these medications are not enough to control their asthma. Recently, several new medications, known collectively as “biologics,” have been approved for the…